Pélissier Géraldine, Bastides Frédéric
Hôpital Bretonneau, CHU de Tours, 37044 Tours Cedex 01, France.
Rev Prat. 2008 Dec 15;58(19 Suppl):25-31.
General practitioners are the first line to promote the human papillomavirus vaccine in teenagers and young female adults. The goal of this study is: to describe the perception, in France, of this vaccine by the general practitioners in the first 6 months after the publication of national recommendations and reimbursement of this vaccine by the Social security; to know the daily practice of the cervical cancer prevention. These questions were asked through a questionnaire sent to 545 general practitioners s in the Eure-et-Loir and Cher departments. We got 255 answers (46%); 73% have already use this vaccine, at least once, and 64% are ready to promote this immunization in girls over the age of 14.70% think the national recommendations can be applied without any negative impact on the cervical cancer screening by the cervical-smear because human papillomavirus vaccine do not eliminate the need of cervical cancer screening; 81% are motivated to justify this immunization in their patients even if 10% spontaneously mention the problem of the hepatitis B immunization in France as a limitation to implementation of a new vaccine. Although these results are encouraging, cervical cancer screening should be intensified and general practitioners, patients and their parents should get better information.